METHYLIN Side Effects

6979377-9 | Pneumonia Mycoplasmal
on Sep 03, 2010 Female patient from UNITED STATES , child 3 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia mycoplasmal. Methylin dosage: Unk.

6979376-7 | Convulsion
Patient was taking Methylin (View Usage). Patient had the following side effects: convulsion on Sep 03, 2010 from UNITED STATES Additional patient health information: Male patient , child 3 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Methylin dosage: 5 Mg, Unk.

6979375-5 | Faecaloma
Adverse event was reported on Sep 03, 2010 by a Female patient taking Methylin (View Usage) (Dosage: Unk) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 3 years of age, After Methylin was administered, patient had the following side effects: faecaloma. Patient was hospitalized.

6979372-X | Migraine
on Sep 03, 2010 Female patient from UNITED STATES , child 3 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: migraine (What is migraine?). Methylin dosage: Unk. Patient was hospitalized.


6979370-6 | Aggression
on Sep 03, 2010 Female patient from UNITED STATES , child 3 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). Patient had the following side effects: aggression. Methylin dosage: Unk. Patient was hospitalized.

6866057-3 | Abnormal Behaviour, Agitation, Anxiety, Personality Change, Social Avoidant Behaviour, Suicidal Ideation, Vomiting
Patient was taking Methylin (View Usage). After Methylin was administered, patient had the following side effects: abnormal behaviour, agitation, anxiety (What is anxiety?), personality change, social avoidant behaviour, suicidal ideation, vomiting on Jul 13, 2010 from UNITED STATES Additional patient health information: Male patient , child 7 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Methylin dosage: Unk,one In The Morning And Afternoon.

6809310-1 | Incorrect Dose Administered, Mania, Serotonin Syndrome
Adverse event was reported on Jun 24, 2010 by a Male patient taking Methylin (View Usage) (Dosage: 10 Mg, Qd For One Month) was diagnosed with major depression and. Location: KOREA, REPUBLIC OF , 18 years of age, Patient experienced the following unwanted or unexpected effects: incorrect dose administered, mania, serotonin syndrome. During the same period patient was treated with PAROXETINE (20 Mg, Qd For One Month) (View Paroxetine Review and Paroxetine Label ). Patient was hospitalized.

6760837-0 | Abdominal Pain, Product Substitution Issue
on Jun 07, 2010 Male patient from UNITED STATES , child 8 years of age, weighting 84.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), product substitution issue. Methylin dosage: 2 5mg Tablets Morning Po.

6733419-4 | Acute Myocardial Infarction
on May 05, 2010 Male patient from UNITED STATES , 27 years of age, was diagnosed with attention deficit/hyperactivity disorder, sinusitis (What is sinusitis?) and was treated with Methylin (View Usage). After Methylin was administered, patient had the following side effects: acute myocardial infarction. Methylin dosage: 5 Mg, Bid. During the same period patient was treated with CEFDINIR (View Cefdinir Review and Cefdinir Label ), FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCL (View Fexofenadine Hcl And Pseudoephedrine Hcl Review and Fexofenadine Hcl And Pseudoephedrine Hcl Label ). Patient was hospitalized.

6689897-2 | Fatigue, Sluggishness
Patient was taking Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, sluggishness on Mar 16, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Methylin dosage: 40 Mg, Qd, Prn. During the same period patient was treated with WELLBUTRIN (Unk, Qd) (View Wellbutrin Review and Wellbutrin Label ).

6689896-0 | Abdominal Discomfort, Incorrect Dose Administered
Adverse event was reported on Dec 18, 2009 by a Male patient taking Methylin (View Usage) (Dosage: 25 Mg, Qid) was diagnosed with narcolepsy and. Location: UNITED STATES , 32 years of age, Patient had the following side effects: abdominal discomfort, incorrect dose administered.

6689895-9 | Tic, Weight Decreased
on May 15, 2009 Male patient from UNITED STATES , child 6 years of age, weighting 43.99 lb, was diagnosed with attention deficit/hyperactivity disorder, asthma (What is asthma?) and was treated with Methylin (View Usage). After Methylin was administered, patient had the following side effects: tic (What is tic?), weight decreased. Methylin dosage: 10 Mg, Qd. During the same period patient was treated with ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ).

6684029-9 | Agitation, Blood Pressure Increased, Confusional State, Delusion, Depressed Mood, Hallucination, Heart Rate Increased, Irritability, Mood Swings
on Apr 02, 2010 Female patient from TURKEY , child 8 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, blood pressure increased, confusional state, delusion, depressed mood, hallucination, heart rate increased, irritability, mood swings. Methylin dosage: 210 Mg. Patient was hospitalized.

6684028-7 | Abnormal Behaviour, Agitation, Personality Change, Social Avoidant Behaviour, Suicidal Ideation
Patient was taking Methylin (View Usage). Patient had the following side effects: abnormal behaviour, agitation, personality change, social avoidant behaviour, suicidal ideation on Apr 05, 2010 from UNITED STATES Additional patient health information: Male patient , child 7 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Methylin dosage: Unk,one In The Morning And Afternoon.

6598717-6 | Completed Suicide
Adverse event was reported on Jan 05, 2010 by a Male patient taking Methylin (View Usage) (Dosage: ) . Location: UNITED STATES , 21 years of age, After Methylin was administered, patient had the following side effects: completed suicide. During the same period patient was treated with ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6598696-1 | Cardiac Arrest, Cardio-respiratory Arrest, Completed Suicide
on Jan 05, 2010 Female patient from UNITED STATES , 57 years of age, was treated with Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, completed suicide. Methylin dosage: . During the same period patient was treated with DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), CELECOXIB (View Celecoxib Review and Celecoxib Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6574590-7 | Myocardial Infarction, Off Label Use, Panic Attack
on Jan 27, 2010 Male patient from UNITED STATES , weighting 247.4 lb, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Methylin (View Usage). Patient had the following side effects: myocardial infarction, off label use, panic attack. Methylin dosage: 20 Mg, Tid. During the same period patient was treated with CYMBALTA (30 Mg, Unk) (View Cymbalta Review and Cymbalta Label ), CLONAZEPAM (0.5 Mg, Unk) (View Clonazepam Review and Clonazepam Label ), ABILIFY (2 Mg, Unk) (View Abilify Review and Abilify Label ), PRAVASTATIN (40 Mg, Unk) (View Pravastatin Review and Pravastatin Label ), ZOLPIDEM (10 Mg, Unk) (View Zolpidem Review and Zolpidem Label ), RAMIPRIL (5 Mg, Unk) (View Ramipril Review and Ramipril Label ), BUPROPION (Unk) (View Bupropion Review and Bupropion Label ), METOPROLOL TARTRATE (26 Mg, Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6564376-1 | Completed Suicide
Patient was taking Methylin (View Usage). After Methylin was administered, patient had the following side effects: completed suicide on Jan 05, 2010 from UNITED STATES Additional patient health information: Female patient , 14 years of age, . Methylin dosage: Unk. During the same period patient was treated with SALICYLATES NOS (Unk) (View Salicylates Nos Review and Salicylates Nos Label ), LAMOTRIGINE (Unk) (View Lamotrigine Review and Lamotrigine Label ), LITHIUM (Unk) (View Lithium Review and Lithium Label ).

6504269-9 |
Adverse event was reported on Dec 07, 2009 by a Female patient taking Methylin (View Usage) (Dosage: Unk) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED KINGDOM , 16 years of age, .

6504267-5 | Injury
on Dec 07, 2009 Female patient from UNITED KINGDOM , 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). Patient had the following side effects: injury. Methylin dosage: .

6504266-3 | Completed Suicide
on Dec 07, 2009 Female patient from UNITED KINGDOM , child 8 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). After Methylin was administered, patient had the following side effects: completed suicide. Methylin dosage: Unk.

6504264-X | Completed Suicide
Patient was taking Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Dec 07, 2009 from UNITED KINGDOM Additional patient health information: Female patient , child 8 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Methylin dosage: Unk.

6504263-8 | Overdose
Adverse event was reported on Dec 07, 2009 by a Female patient taking Methylin (View Usage) (Dosage: Unk) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED KINGDOM , 16 years of age, Patient had the following side effects: overdose.

6490948-9 | Abasia, Asthenia, Disorientation
on Mar 24, 2009 Female patient from UNITED STATES , 52 years of age, weighting 239.9 lb, was diagnosed with fatigue, crying and was treated with Methylin (View Usage). After Methylin was administered, patient had the following side effects: abasia, asthenia, disorientation. Methylin dosage: 10 Mg, Qid. During the same period patient was treated with PROZAC /00724401/ (20 Mg, Prn) (View Prozac /00724401/ Review and Prozac /00724401/ Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), PRILOSEC (Unk) (View Prilosec Review and Prilosec Label ), STEROIDS (Unk) (View Steroids Review and Steroids Label ).

6490947-7 | Aggression, Anxiety, Dizziness, Refusal Of Treatment By Patient, Vision Blurred
on Feb 16, 2009 Male patient from UNITED STATES , weighting 41.99 lb, was diagnosed with attention deficit/hyperactivity disorder, insomnia and was treated with Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, anxiety (What is anxiety?), dizziness (What is dizziness?), refusal of treatment by patient, vision blurred. Methylin dosage: 5 Mg, 1 Tab Before Breakfast, Lunch, Between 3-4 Pm, Daily. During the same period patient was treated with MELATONIN (3 Mg, 1 Tab At Bed Time Prn) (View Melatonin Review and Melatonin Label ).

6490946-5 | Anxiety, Delusion, Feeling Abnormal, Hyperhidrosis, Insomnia
Patient was taking Methylin (View Usage). Patient had the following side effects: anxiety (What is anxiety?), delusion, feeling abnormal, hyperhidrosis, insomnia on Jun 15, 2009 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with narcolepsy and. Methylin dosage: 5 Mg, (1/2 Tab) Bid (am Pm).

6490945-3 | Chest Pain, Dyspnoea
Adverse event was reported on May 18, 2009 by a Male patient taking Methylin (View Usage) (Dosage: Unk) was diagnosed with attention deficit/hyperactivity disorder, prophylaxis and. Location: UNITED STATES , 49 years of age, After Methylin was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea. During the same period patient was treated with LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ).

6490944-1 | Abdominal Pain, Diarrhoea, Flatulence, Nausea
on Jul 01, 2009 Female patient from UNITED STATES , 82 years of age, weighting 168.0 lb, was diagnosed with narcolepsy, hypertension, hypothyroidism, atrial fibrillation (What is atrial fibrillation?) and was treated with Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, flatulence, nausea (What is nausea?). Methylin dosage: 10 Mg, Qid. During the same period patient was treated with DIOVAN /01319601/ (180 Mg, Qd) (View Diovan /01319601/ Review and Diovan /01319601/ Label ), SYNTHROID (0.1 Mg, Qd) (View Synthroid Review and Synthroid Label ), SOTALOL HCL (80 Mg, Qd) (View Sotalol Hcl Review and Sotalol Hcl Label ).

6490937-4 | Off Label Use, Skin Lesion
on May 07, 2009 Male patient from UNITED STATES , weighting 235.0 lb, was diagnosed with asthenia, liver transplant (What is liver transplant?), blood pressure increased, antibiotic prophylaxis, blood cholesterol increased, pain (What is pain?) and was treated with Methylin (View Usage). Patient had the following side effects: off label use, skin lesion. Methylin dosage: 20 Mg, Bid. During the same period patient was treated with PROGRAF (25 Mg, Qd) (View Prograf Review and Prograf Label ), ISOSORBIDE (Unk) (View Isosorbide Review and Isosorbide Label ), METOPROLOL (Unk) (View Metoprolol Review and Metoprolol Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), SEPTRA (1 Qd) (View Septra Review and Septra Label ), LOTREL (Bid) (View Lotrel Review and Lotrel Label ), SIMVASTATIN (80 Mg, Unk) (View Simvastatin Review and Simvastatin Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (1 Bid) (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ).

6490936-2 | Deafness
Patient was taking Methylin (View Usage). After Methylin was administered, patient had the following side effects: deafness on Dec 15, 2008 from UNITED STATES Additional patient health information: Male patient , child 9 years of age, . Methylin dosage: Unk.

6490934-9 | Oppositional Defiant Disorder
Adverse event was reported on Feb 06, 2009 by a Male patient taking Methylin (View Usage) (Dosage: Unk) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , weighting 48.99 lb, Patient experienced the following unwanted or unexpected effects: oppositional defiant disorder.

6377989-7 |
on Sep 15, 2009 Female patient from UNITED STATES , 15 years of age, weighting 104.9 lb, was treated with Methylin (View Usage). . Methylin dosage: . During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ).

6377988-5 |
on Sep 15, 2009 Male patient from UNITED STATES , child 12 years of age, weighting 87.96 lb, was treated with Methylin (View Usage). . Methylin dosage: 5 Mg, Tid.

6377987-3 |
Patient was taking Methylin (View Usage). on Sep 15, 2009 from UNITED STATES Additional patient health information: Female patient , child 11 years of age, . Methylin dosage: Unk.

6377986-1 |
Adverse event was reported on Sep 15, 2009 by a Male patient taking Methylin (View Usage) (Dosage: Unk) . Location: UNITED STATES , 13 years of age, weighting 121.0 lb, .

6377984-8 |
on Sep 15, 2009 Male patient from UNITED STATES , 13 years of age, was treated with Methylin (View Usage). . Methylin dosage: Unk.

6377983-6 |
on Sep 15, 2009 Male patient from UNITED STATES , child 9 years of age, weighting 63.93 lb, was treated with Methylin (View Usage). . Methylin dosage: . During the same period patient was treated with BUPROPION (View Bupropion Review and Bupropion Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ).

6377981-2 |
Patient was taking Methylin (View Usage). on Sep 15, 2009 from UNITED STATES Additional patient health information: Male patient , child 7 years of age, weighting 61.95 lb, . Methylin dosage: .

6377980-0 | Road Traffic Accident
Adverse event was reported on Sep 15, 2009 by a Male patient taking Methylin (View Usage) (Dosage: Unk, Once A Day) . Location: UNITED STATES , 15 years of age, After Methylin was administered, patient had the following side effects: road traffic accident.

6377979-4 |
on Sep 15, 2009 Male patient from UNITED STATES , child 9 years of age, weighting 65.92 lb, was treated with Methylin (View Usage). . Methylin dosage: 10 Mg, Bid.

6377978-2 |
on Sep 15, 2009 Male patient from UNITED STATES , 18 years of age, was treated with Methylin (View Usage). . Methylin dosage: Unk.

6377977-0 |
Patient was taking Methylin (View Usage). on Sep 15, 2009 from UNITED STATES Additional patient health information: Male patient , child 12 years of age, weighting 104.9 lb, . Methylin dosage: Unk, Tid.

6282258-X | Condition Aggravated, Disturbance In Attention, Educational Problem, Headache, Memory Impairment, Product Substitution Issue
Adverse event was reported on Jul 21, 2009 by a Male patient taking Methylin (View Usage) (Dosage: 20 Mg 1 Po Bid) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 18 years of age, weighting 156.0 lb, Patient experienced the following unwanted or unexpected effects: condition aggravated, disturbance in attention, educational problem, headache (What is headache?), memory impairment, product substitution issue. During the same period patient was treated with METHYLPHENIDATE HYDROCHLORIDE (20 Mg 1 Po Bid) (View Methylphenidate Hydrochloride Review and Methylphenidate Hydrochloride Label ).

6148417-1 | Abdominal Pain Upper, Vomiting
on Apr 06, 2009 Female patient from UNITED STATES , child 7 years of age, weighting 87.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). Patient had the following side effects: abdominal pain upper, vomiting. Methylin dosage: 2 1/2 Ml By Mouth In Morning.

6138549-6 | Completed Suicide
on Jan 30, 2009 Female patient from UNITED STATES , 22 years of age, was treated with Methylin (View Usage). After Methylin was administered, patient had the following side effects: completed suicide. Methylin dosage: . During the same period patient was treated with EPHEDRA (View Ephedra Review and Ephedra Label ), ETHANOL (View Ethanol Review and Ethanol Label ), VALERIAAN /01561606/ (View Valeriaan /01561606/ Review and Valeriaan /01561606/ Label ).

6138062-6 | Completed Suicide
Patient was taking Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Jan 30, 2009 from UNITED STATES Additional patient health information: Male patient , 65 years of age, . Methylin dosage: . During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), TRANYLCYPROMINE SULFATE (View Tranylcypromine Sulfate Review and Tranylcypromine Sulfate Label ), AMPHETAMINE AND DEXTROAMPHETAMINE SALTS (View Amphetamine And Dextroamphetamine Salts Review and Amphetamine And Dextroamphetamine Salts Label ), CARBON MONOXIDE (View Carbon Monoxide Review and Carbon Monoxide Label ), MODAFINIL (View Modafinil Review and Modafinil Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), TIAGABINE HCL (View Tiagabine Hcl Review and Tiagabine Hcl Label ).

6108285-0 | Cardio-respiratory Arrest, Completed Suicide
Adverse event was reported on Jan 30, 2009 by a Female patient taking Methylin (View Usage) (Dosage: ) . Location: UNITED STATES , 46 years of age, Patient had the following side effects: cardio-respiratory arrest, completed suicide. During the same period patient was treated with METHADOSE (View Methadose Review and Methadose Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6108043-7 | Hypoaesthesia
on Mar 05, 2009 Male patient from UNITED STATES , child 7 years of age, weighting 49.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). After Methylin was administered, patient had the following side effects: hypoaesthesia. Methylin dosage: 10 Mg. 2x A Day Po.

6017907-4 | Anoxic Encephalopathy, Cardiac Arrest, Coma, Convulsion, Electromechanical Dissociation, Loss Of Consciousness, Ventricular Fibrillation
on Dec 10, 2008 Male patient from UNITED STATES , 17 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Methylin (View Usage). Patient experienced the following unwanted or unexpected effects: anoxic encephalopathy, cardiac arrest (What is cardiac arrest?), coma, convulsion, electromechanical dissociation, loss of consciousness, ventricular fibrillation. Methylin dosage: 18 Mg, Qd. Patient was hospitalized.

5771970-4 | Haemorrhagic Stroke
Patient was taking Methylin (View Usage). Patient had the following side effects: haemorrhagic stroke on Jun 12, 2008 from UNITED STATES Additional patient health information: Female patient , 21 years of age, weighting 115.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Methylin dosage: 20 Mg 3 Per Day. Patient was hospitalized.